Cargando…

Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy

Background: Gender dysphoria is defined as a feeling of distress resulting from the incongruence between the sex assigned at birth and the gender identity, lasting longer than 6 months. In individuals with gender dysphoria, gender-affirming hormone therapy (GAHT) may improve quality of life (QoL). O...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Eliane D., Fighera, Tayane M., Allgayer, Roberta M., Lobato, Maria Inês R., Spritzer, Poli Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350045/
https://www.ncbi.nlm.nih.gov/pubmed/34381383
http://dx.doi.org/10.3389/fpsyt.2021.621075
_version_ 1783735666877661184
author Silva, Eliane D.
Fighera, Tayane M.
Allgayer, Roberta M.
Lobato, Maria Inês R.
Spritzer, Poli Mara
author_facet Silva, Eliane D.
Fighera, Tayane M.
Allgayer, Roberta M.
Lobato, Maria Inês R.
Spritzer, Poli Mara
author_sort Silva, Eliane D.
collection PubMed
description Background: Gender dysphoria is defined as a feeling of distress resulting from the incongruence between the sex assigned at birth and the gender identity, lasting longer than 6 months. In individuals with gender dysphoria, gender-affirming hormone therapy (GAHT) may improve quality of life (QoL). Objectives: We aimed to assess perceived QoL, to compare QoL scores between trans women and men and to identify possible contributing factors related to GAHT in a sample of transgender women and transgender men. Methods: In this cross-sectional study, transgender women and men were recruited by availability sampling from a national transgender health service. Individuals over 18 years old with a confirmed diagnosis of gender dysphoria receiving medically prescribed GAHT for at least 6 months were consecutively included. Also included were trans men who had undergone mastectomy and trans women who had received breast augmentation surgery. Individuals who had undergone gender affirmation surgery (specifically genital surgery) or with uncontrolled clinical/psychiatric conditions at the time of the initial assessment were excluded. Sociodemographic, physical, and hormone data were collected from all participants. The WHOQOL-BREF questionnaire was used to evaluate QoL. A total of 135 transgender individuals were invited. Seventeen individuals with previous genital surgery (12.6%) and five who refused to participate (3.7%) were excluded. Therefore, 113 patients were enrolled and completed the study (60 trans women and 53 trans men). Results: QoL scores did not differ between trans women and trans men. In trans women, greater breast development and stable relationships, and higher body mass index were associated with higher QoL domain scores. In trans men, higher domain scores were found in individuals in a stable relationship, with increased body hair, engaging in physical activity, and being employed. Conclusion: Data from this study suggest that GAHT-related physical characteristics, such as breast development in trans women and increased body hair in trans men, are similar between groups, are associated with higher QoL scores, and that sociodemographic parameters may impact these associations. Healthcare providers might consider these factors when planning interventions to improve QoL in transgender individuals.
format Online
Article
Text
id pubmed-8350045
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83500452021-08-10 Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy Silva, Eliane D. Fighera, Tayane M. Allgayer, Roberta M. Lobato, Maria Inês R. Spritzer, Poli Mara Front Psychiatry Psychiatry Background: Gender dysphoria is defined as a feeling of distress resulting from the incongruence between the sex assigned at birth and the gender identity, lasting longer than 6 months. In individuals with gender dysphoria, gender-affirming hormone therapy (GAHT) may improve quality of life (QoL). Objectives: We aimed to assess perceived QoL, to compare QoL scores between trans women and men and to identify possible contributing factors related to GAHT in a sample of transgender women and transgender men. Methods: In this cross-sectional study, transgender women and men were recruited by availability sampling from a national transgender health service. Individuals over 18 years old with a confirmed diagnosis of gender dysphoria receiving medically prescribed GAHT for at least 6 months were consecutively included. Also included were trans men who had undergone mastectomy and trans women who had received breast augmentation surgery. Individuals who had undergone gender affirmation surgery (specifically genital surgery) or with uncontrolled clinical/psychiatric conditions at the time of the initial assessment were excluded. Sociodemographic, physical, and hormone data were collected from all participants. The WHOQOL-BREF questionnaire was used to evaluate QoL. A total of 135 transgender individuals were invited. Seventeen individuals with previous genital surgery (12.6%) and five who refused to participate (3.7%) were excluded. Therefore, 113 patients were enrolled and completed the study (60 trans women and 53 trans men). Results: QoL scores did not differ between trans women and trans men. In trans women, greater breast development and stable relationships, and higher body mass index were associated with higher QoL domain scores. In trans men, higher domain scores were found in individuals in a stable relationship, with increased body hair, engaging in physical activity, and being employed. Conclusion: Data from this study suggest that GAHT-related physical characteristics, such as breast development in trans women and increased body hair in trans men, are similar between groups, are associated with higher QoL scores, and that sociodemographic parameters may impact these associations. Healthcare providers might consider these factors when planning interventions to improve QoL in transgender individuals. Frontiers Media S.A. 2021-07-26 /pmc/articles/PMC8350045/ /pubmed/34381383 http://dx.doi.org/10.3389/fpsyt.2021.621075 Text en Copyright © 2021 Silva, Fighera, Allgayer, Lobato and Spritzer. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Silva, Eliane D.
Fighera, Tayane M.
Allgayer, Roberta M.
Lobato, Maria Inês R.
Spritzer, Poli Mara
Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
title Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
title_full Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
title_fullStr Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
title_full_unstemmed Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
title_short Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
title_sort physical and sociodemographic features associated with quality of life among transgender women and men using gender-affirming hormone therapy
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350045/
https://www.ncbi.nlm.nih.gov/pubmed/34381383
http://dx.doi.org/10.3389/fpsyt.2021.621075
work_keys_str_mv AT silvaelianed physicalandsociodemographicfeaturesassociatedwithqualityoflifeamongtransgenderwomenandmenusinggenderaffirminghormonetherapy
AT figheratayanem physicalandsociodemographicfeaturesassociatedwithqualityoflifeamongtransgenderwomenandmenusinggenderaffirminghormonetherapy
AT allgayerrobertam physicalandsociodemographicfeaturesassociatedwithqualityoflifeamongtransgenderwomenandmenusinggenderaffirminghormonetherapy
AT lobatomariainesr physicalandsociodemographicfeaturesassociatedwithqualityoflifeamongtransgenderwomenandmenusinggenderaffirminghormonetherapy
AT spritzerpolimara physicalandsociodemographicfeaturesassociatedwithqualityoflifeamongtransgenderwomenandmenusinggenderaffirminghormonetherapy